Buten Matthew bought BHVN
January 5, 2026 · Form 4 insider transaction
Buten Matthew bought 4,250 shares of Biohaven Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,250
Price
$0.00
Total value
N/A
InsiderButen Matthew
RoleOfficer
CompanyBiohaven Ltd. (BHVN)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after198,246
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025.